Tingting Wang

Dr. Tingting Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
YWYin Wang
Yin Wang
WLWenming Li
Wenming Li
TZTingrui Zhao
Tingrui Zhao
YZYao Zou
Yao Zou
TDTao Deng
Tao Deng
CYChao Yu
Chao Yu
Atherosclerosis is a chronic inflammatory disease. Interleukin-17-producing CD4+ T cells (Th17 cells) play important roles in the progression of atherosclerosis. However, most of the studies were focused on the advanced stage of atherosclerosis. In the current study, we investigated the roles of Th17 cells, relevant mechanisms in hyperlipidemic patients, and different stages of atherosclerotic mice. Human blood samples were collected, and percentages of Th17 cells, macrophages, and neutrophils were analyzed by flow cytometry. ApoE−/− mice were fed with high-fat diet (HFD) and sacrificed at different time points to evaluate the infiltration of inflammatory cells at different stages of atherosclerosis. Furthermore, essential mechanisms of IL-17A in atherosclerotic inflammatory milieu formation were studied in vivo by intraperitoneal injection with monoclonal anti-murine IL-17 antibody. Our study reveals the higher percentages of Th17 cells, monocytes, and neutrophils in hyperlipidemic patients compared to healthy donors. Meanwhile, we also identify an infiltration of Th17 cells in the early stage of atherosclerosis (4 weeks after HFD), which maintains at high level until late stage of atherosclerosis (20 weeks after HFD). What is more, inflammatory cells including macrophages and neutrophils were also accumulated in atherosclerotic lesions. Neutralization of IL-17 in ApoE−/− mice resulted in less infiltration of macrophages and neutrophils and smaller atherosclerotic lesions. Importantly, in accordance with what is found in the mouse model, positive correlations between Th17 cells and macrophages or neutrophils were observed in hyperlipidemic patients. In conclusion, our clinical and mouse model data together reveal a pro-atherogenic role of Th17 cells through the promotion of inflammation in hyperlipidemic conditions and different stages of atherosclerosis, which further supports the notion that IL-17 may be a therapy target for the treatment of atherosclerosis.

17 February 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
TZTingrui Zhao
Tingrui Zhao
QJQingsong Jiang
Qingsong Jiang
WLWenming Li
Wenming Li
YWYin Wang
Yin Wang
YZYao Zou
Yao Zou
TWTingting Wang
Tingting Wang
Neutrophils constitute abundant cellular components in atherosclerotic plaques. Most of the current studies are focused on the roles of granular proteins released by neutrophils in atherosclerosis. Here, we revealed a unique subset of neutrophils which exhibit the characteristics of antigen-presenting cell (APC) (which were called APC-like neutrophils afterwards) in atherosclerosis. The roles of APC-like neutrophils and relevant mechanisms were investigated in hyperlipidemic patients and atherosclerotic mice. Higher percentages of neutrophils and APC-like neutrophils were found in peripheral blood of hyperlipidemic patients than that of healthy donors. Meanwhile, we also identified higher infiltration of neutrophils and APC-like neutrophils in atherosclerotic mice. Ox-LDL induced Phorbol-12-myristate-13-acetate (PMA)-activated neutrophils to acquire the APC-like phenotype. Importantly, upon over-expression of APC-like markers, neutrophils acquired APC functions to promote the proliferation and interferon-γ production of CD3+ T cells via HLA-DR/CD80/CD86. In accordance with what found in vitro, positive correlation between neutrophils and CD3+ T cells was observed in hyperlipidemic patients. In conclusion, our work identifies a proinflammatory neutrophil subset in both hyperlipidemic patients and atherosclerotic mice. This unique phenotype of neutrophils could activate the adaptive immune response to promote atherosclerosis progression. Thus, this neutrophil subset may be a new target for immunotherapy of atherosclerosis.

1 June 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
YWYin Wang
Yin Wang
YZYao Zou
Yao Zou
QJQingsong Jiang
Qingsong Jiang
WLWenming Li
Wenming Li
XCXinyu Chai
Xinyu Chai
TWTingting Wang
Tingting Wang
This work proposed the ox-LDL-CD80+ monocyte/macrophage-CD1d-NKT cell-IFN-γ axis in the progression of atherosclerosis. The proinflammatory IFN-γ+ NKT cells are closely related to CD1d+CD80+ monocytes in hyperlipidemic patients. Inhibiting CD80+ macrophages to present lipid antigens to NKT cells through CD1d blocking may be a new therapeutic target for atherosclerosis.

11 January 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
PLPan Li
Pan Li
RZRuoyu Zhang
Ruoyu Zhang
PHPingping Hu
Pingping Hu
TWTingting Wang
Tingting Wang
JWJianwei Wang
Jianwei Wang

Verified
Journal Article
Open access
PDF file
PLPan Li
Pan Li
TWTingting Wang
Tingting Wang
HQHongmei Qiu
Hongmei Qiu
RZRuoyu Zhang
Ruoyu Zhang
CYChao Yu
Chao Yu
JWJianwei Wang
Jianwei Wang
Metabolic-associated fatty liver disease (MAFLD), also known as non-alcoholic fatty liver disease (NAFLD), is a worldwide liver disease without definitive or widely used therapeutic drugs in clinical practice. In this study, we confirm that 6-gingerol (6-G), an active ingredient of ginger (Zingiber officinale Roscoe) in traditional Chinese medicine (TCM), can alleviate fructose-induced hepatic steatosis. It was found that 6-G significantly decreased hyperlipidemia caused by high-fructose diets (HFD) in rats, and reversed the increase in hepatic de novo lipogenesis (DNL) and triglyceride (TG) levels induced by HFD, both in vivo and in vitro. Mechanistically, chemical proteomics and cellular thermal shift assay (CETSA)–proteomics approaches revealed that stearoyl-CoA desaturase (SCD) is a direct binding target of 6-G, which was confirmed by further CETSA assay and molecular docking. Meanwhile, it was found that 6-G could not alter SCD expression (in either mRNA or protein levels), but inhibited SCD activity (decreasing the desaturation levels of fatty acids) in HFD-fed rats. Furthermore, SCD deficiency mimicked the ability of 6-G to reduce lipid accumulation in HF-induced HepG2 cells, and impaired the improvement in hepatic steatosis brought about by 6-G treatment in HFD supplemented with oleic acid diet-induced SCD1 knockout mice. Taken together, our present study demonstrated that 6-G inhibits DNL by targeting SCD to alleviate fructose diet-induced hepatic steatosis.

7 March 2026 in Cell Communication and Signaling
Verified
Journal Article
Open access
YWYin Wang
Yin Wang
PLPan Li
Pan Li
WLWenming Li
Wenming Li
YZYao Zou
Yao Zou
YZYing Zhao
Ying Zhao
CYChao Yu
Chao Yu
Tc17 cells (IL-17 + CD8+T) are found in many inflammatory diseases. However, the distribution, regulation, and function of Tc17 cells in ApoE deficient-induced atherosclerosis are currently largely unexplored. The percentage of Tc17 cells, monocytes and IL-1β+ monocytes in blood of hyperlipidemic patients or healthy donors were analyzed by flow cytometry. The content of IL-1β in plasma was detected by ELISA. Correlations between parameters of clinical samples were assessed using Spearman r correlation analysis or linear regression analysis as appropriate. Aorta, blood, spleen, and bone marrow of atherosclerotic mice with different stages were collected for flow cytometry to analyze the percentage of Tc17 cells and monocytes/macrophages. Hearts were collected for Oil Red O staining, Masson’s staining, immunofluorescence staining or immunohistochemistry staining. GEO database (GSE43292) was used to analyze the expression of Tc17 cell-related inducers in plaques of AS patients. CD8+T cells and macrophages were isolated for ex vivo function assays. Adoptive transfer and IL-1β neutralization experiments were utilized for in vivo mechanism assays. Higher populations of Tc17 cells, IL-1β+monocytes or CD80+ monocytes were found in the peripheral blood of hyperlipidemic patients compared to that in healthy donors. In addition, positive correlation between Tc17 cells and CD80+ monocytes was observed in hyperlipidemic patients. Furthermore, Tc17 cells and CD80+ monocytes/macrophages increased in the aorta, blood, spleen, and bone marrow of atherosclerotic mice, reaching the highest level on week 12 post feeding. Based on the analysis of GSE43292, we found increased IL-1β expression in AS plaques, not the other inducing differentiation factors of Tc17 cells, compared to normal tissues. Finally, ex vivo co-culture and transwell experiment and in vivo adoptive transfer and IL-1β neutralization experiments confirmed that CD80+ macrophages promoted Tc17 cells expansion by IL-1β in vascular lesions and facilitated murine atherosclerotic progression. The present results show that suppressing IL-1β expression by preventing CD80+ macrophage polarization may alleviate atherosclerosis through the reduction of Tc17 cells in atherosclerotic lesions. Our study demonstrates that decreasing Tc17 cells population by the inhibition of CD80+ macrophage-derived IL-1β is a potentially promising therapeutic strategy for the treatment of atherosclerosis. IL-17+CD8+ T cells (Tc17 cells) accumulate in atherosclerosis due to CD80+ macrophage-derived IL-1β; releasing of IL-17 by Tc17 cells exacerbates atherosclerosis progression, which is characterized by the accumulation of lipids in blood vessel walls and the formation of atherosclerotic plaques. This figure was drawn by Figdraw. The online version contains supplementary material available at 10.1186/s12964-026-02785-4.